# Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide

> **NCT00213031** · PHASE2 · COMPLETED · sponsor: **Population Council** · enrollment: 165 (—)

## Conditions studied

- HIV Infections
- Chlamydia Trachomatis
- Neisseria Gonorrhoeae
- Trichomonas Vaginitis
- Syphilis
- Herpes Simplex

## Interventions

- **DRUG:** Carraguard (PC-515)

## Key facts

- **NCT ID:** NCT00213031
- **Lead sponsor:** Population Council
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** —
- **Final completion:** 2001-12
- **Target enrollment:** 165 (—)
- **Last updated:** 2017-08-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213031, "Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00213031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*